Ampio has so much it is hard to believe anyone would actually sell. No doubt once the Ampion trial data is released within the next 4-6 weeks IMO, a Zertane Deal, OPtima progress, MOre OPN device news coupled with the overseas activity, coupled with a low float and no debt would indicate that the stock will be 3 times the target prices if not bigger. The recent author from the street must be the dumbest spammer i have ever seen. it is obvious the fellow is short. When i think of all the juice this company has and the fact that they rapidly made it on the NAZ and then NYSE tells me that no doubt this will explode come data and deal time. BUY NOW!!